Autobio Diagnostics (SHA:603658) secondary Zhengzhou Biaoyuan voluntarily canceled its medical device operating license and Class Two medical device operating filing certificate.
The move is part of an internal business restructuring and resource integration strategy, according to a Tuesday aftermarket filing with the Shanghai bourse.
Shares of the medical technology company closed 3% lower Wednesday.